The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

Unlike many existing smart garments, the shirt—dubbed SeamFit—doesn’t rely on bulky sensors or a tight, restrictive fit. The ...

The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.